<DOC>
	<DOCNO>NCT00746941</DOCNO>
	<brief_summary>The primary objective study explore whether mefloquine delay stop progression progressive multifocal leukoencephalopathy ( PML ) measure JC virus ( human polyomavirus JCV ) deoxyribonucleic acid ( DNA ) level cerebrospinal fluid ( CSF ) . The secondary objective study explore whether mefloquine delay stop progression PML base neurological deterioration , magnetic resonance imaging ( MRI ) measure brain lesion evolution formation new lesion , mortality .</brief_summary>
	<brief_title>Study Explore Effect Mefloquine Participants With Progressive Multifocal Leukoencephalopathy ( PML )</brief_title>
	<detailed_description />
	<mesh_term>Leukoencephalopathies</mesh_term>
	<mesh_term>Leukoencephalopathy , Progressive Multifocal</mesh_term>
	<mesh_term>Mefloquine</mesh_term>
	<criteria>Key Diagnosis PML confirm detection JCV DNA CSF . Onset PML symptom within 6 month prior study . Key Other opportunistic infection central nervous system . Current severe illness condition , opinion Investigator , would make subject unsuitable enrollment . Active severe mental illness ( e.g. , depression , anxiety , psychosis , schizophrenia ) . Hypersensitivity mefloquine , quinine , quinidine , component drug . Current treatment quinine , quinidine , chloroquine , halofantrine . Note : Other protocoldefined criterion may also apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>PML</keyword>
	<keyword>Human Polyomavirus JC</keyword>
	<keyword>HIV</keyword>
	<keyword>Central Nervous System Disease</keyword>
	<keyword>Mefloquine</keyword>
	<keyword>JC Virus</keyword>
</DOC>